In Hemophilia A and B, a Novel Monoclonal Antibody Reduces Bleeding.

Published Date: 15 Dec 2023

Comparing marstacimab to prophylactic, on-demand treatments, the annualized bleeding rate was lower.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

No Cellphone, Brain Cancer Link; Testosterone Paradox; Breast Density and Cancer

2.

Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk

3.

In Hemophilia A and B, a Novel Monoclonal Antibody Reduces Bleeding.

4.

Pomalidomide Reduces Severe Epistaxis in Hereditary Bleeding Disease.

5.

According to the Lancet, proton beam therapy may shorten the course of treatment for patients with breast cancer.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot